1. Ji, Renchen, Wang, Yuan, Pan, Deyue, Han, Chuanchun, Zhang, Lu. 2024. NUCB2 inhibition antagonizes osteosarcoma progression and promotes anti-tumor immunity through inactivating NUCKS1/CXCL8 axis. In Cancer letters, 591, 216893. doi:10.1016/j.canlet.2024.216893. https://pubmed.ncbi.nlm.nih.gov/38636892/
2. Taskin, Mine Islimye, Eser, Betul, Adali, Ertan, Cuce, Coskun, Hismiogulları, Adnan Adil. 2015. NUCB2 gene polymorphism and its relationship with nesfatin-1 levels in polycystic ovary syndrome. In Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 32, 46-50. doi:10.3109/09513590.2015.1081682. https://pubmed.ncbi.nlm.nih.gov/26369257/
3. Wei, Yanyan, Li, Jiangbo, Wang, Huiling, Wang, Gaohua. 2017. NUCB2/nesfatin-1: Expression and functions in the regulation of emotion and stress. In Progress in neuro-psychopharmacology & biological psychiatry, 81, 221-227. doi:10.1016/j.pnpbp.2017.09.024. https://pubmed.ncbi.nlm.nih.gov/28963067/
4. Wang, Chunyu, Wang, Yulun, Hu, Wenchao. 2017. Association of the polymorphism in NUCB2 gene and the risk of type 2 diabetes. In Diabetology & metabolic syndrome, 9, 39. doi:10.1186/s13098-017-0235-z. https://pubmed.ncbi.nlm.nih.gov/28533821/
5. Zegers, Doreen, Beckers, Sigri, de Freitas, Fenna, Van Gaal, Luc F, Van Hul, Wim. 2012. Identification of mutations in the NUCB2/nesfatin gene in children with severe obesity. In Molecular genetics and metabolism, 107, 729-34. doi:10.1016/j.ymgme.2012.10.014. https://pubmed.ncbi.nlm.nih.gov/23141462/
6. Nakata, Masanori, Yada, Toshihiko. . Role of NUCB2/nesfatin-1 in glucose control: diverse functions in islets, adipocytes and brain. In Current pharmaceutical design, 19, 6960-5. doi:. https://pubmed.ncbi.nlm.nih.gov/23537085/
智鼠故事 
